Finance
Biomedical company reports 11% first quarter revenue increase, maintains guidance
Published in Women's Health Weekly, November 13th, 2003
The company reported a consolidated loss of $843,000, or $0.07 per share, for the current quarter compared to a loss of $1,046,000, or $0.08 per share, for the first fiscal quarter of a year ago.
The loss was in line with previous guidance and continues to reflect the impact of reduced gynecologic sales, unused hyaluronan-manufacturing capacity charges, and consulting and professional fee expenses associated with the market withdrawal of Gynecare...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Exercise, healthy weight delay cancer among women with highest genetic risk - Contraception
A single dose of mifepristone could be used as a monthly birth control pill - Cervical Cancer
Study suggests many women can safely extend screening interval to 3 years - Mental Health
Survey finds majority of women still see depression as a personality flaw - Neuroscience
Women with epilepsy face special issues around the time of menopause - Obstetrics
DHA regulates postpartum depressive symptoms - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
